Status:

RECRUITING

International Cardiac Amyloidosis Registry

Lead Sponsor:

Leiden University Medical Center

Collaborating Sponsors:

Pfizer

Conditions:

Cardiac Amyloidosis

Eligibility:

All Genders

18+ years

Brief Summary

Cardiac amyloidosis is a relatively rare disease. However, with the newer imaging techniques that have become available to us in recent years, determining the diagnosis is becoming more common. There ...

Detailed Description

Rationale: Patients with cardiac amyloidosis are in general underdiagnosed and undertreated. AL amyloidosis is a disease with a very poor prognosis if left untreated. For ATTR amyloidosis, recently, s...

Eligibility Criteria

Inclusion

  • Diagnosed with AL or ATTR cardiac amyloidosis following the recommendations of the European Society of Cardiology \[1\] which include:
  • Signs and symptoms, ECG, echo or CMR suggestive of cardiac amyloidosis and
  • negative hematological test and bone scintigraphy Perugini stage 2 or 3 (is diagnostic for ATTR amyloidosis)
  • negative hematological test and bone scintigraphy Perugini stage 1 and histological confirmation (either extracardiac or cardiac biopsy) with subtyping of ATTR amyloidosis
  • positive hematological test and bone scintigraphy Perugini stage 1-3 and histological confirmation (usually cardiac biopsy) with subtyping of ATTR amyloidosis
  • positive hematological rest and bone scintigraphy Perugini stage 0, MRI consistent with amyloidosis and histological confirmation (either extracardiac or cardiac biopsy) with subtyping AL amyloidosis

Exclusion

  • Unable to provide informed consent due to insufficient language proficiency or intellectual capabilities

Key Trial Info

Start Date :

June 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT06894290

Start Date

June 30 2023

End Date

July 1 2026

Last Update

March 25 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

AZ St Jan

Bruges, Belgium, 8000

2

UZ Antwerpen

Edegem, Belgium, 2650

3

Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma

Roma, Italy, 00168

4

Kitasato University Hospital

Sagamihara, Japan, 252-0375